New York has no plans to change hepatitis B vaccine guidance after a Centers for Disease Control advisory panel voted to stop recommending a first dose for newborns. New York City's acting health commissioner called Friday's vote against longstanding vaccine guidance "concerning and unscientific," adding it will not change recommendations from the city or state.
Main Idea: New York said it will keep recommending the hepatitis B vaccine for newborns after a CDC panel voted to delay the first dose for some babies.
Key Points:
Delaying the newborn hepatitis B shot could leave more babies at risk of infection and long-term liver disease.
New York keeping the birth-dose guidance may help protect infants and keep school vaccine rules stable for families.
Rate how each entity in this article affected the American people.
New York City acting health commissioner quoted as a central decision-maker opposing the CDC panel vote.
Federal public health agency whose advisory panel vote triggered the article.
New York State health commissioner quoted defending the state’s hepatitis B policy.
Named as praising the panel’s move and ordering a broader vaccine schedule review.
Health and Human Services secretary mentioned as appointing the panel members and shaping the context of the vote.
Institution affiliated with Dr. Irwin Redlener, who comments critically on the panel’s decision.
Named expert quoted criticizing the vote and warning about risks to babies.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentFederal department referenced because its secretary appointed the panel members and is tied to the action.